483
Mehran Michael Bahrami, M.D.FDA 483 - Mehran Michael Bahrami, M.D. - April 19, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA issued a Form 483 to Mehran Michael Bahrami, M.D., following an inspection that revealed significant deficiencies in the conduct of clinical investigations. Key issues included failure to obtain informed consent, inadequate oversight of study procedures leading to protocol deviations, and poor record-keeping practices. These findings indicate a lack of adherence to regulatory requirements for human subject protection and data integrity in clinical trials.
Open in Dashboard
ID · 82e9d4ad-347a-4cc9-84e2-d47eb75702dd